#CNBC Lilly’s GLP-1 pill seen as superior in head-to-head trial with Novo’s oral semaglutide
Lilly’s GLP-1 pill seen as superior in head-to-head trial with Novo’s oral semaglutide
CNBC’s Angelica Peebles joins ‘Squawk on the Street’ with the latest details about Eli Lilly’s new drug trial. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Watch CNBC on the go with CNBC+: https://ift.tt/jbyu840
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC on Threads: https://cnb.cx/threads
Follow CNBC News on X: https://cnb.cx/FollowCNBC
Follow CNBC on WhatsApp: https://cnb.cx/WhatsAppCNBC
https://ift.tt/hDeIqlm
#CNBC
#cnbctv
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
#MILENIO
コメントを送信